Back
Dorman Products Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Sell
35
DORM
Dorman Products
Last Price:
$111.15
Seasonality Move:
4.09%
Sell
30
ALNY
Alnylam Pharmaceuticals
Last Price:
$234.56
Seasonality Move:
16.16%
Sell
35
Dorman Products (DORM)
is a Sell
Is Dorman Products a Buy, Sell or Hold?
-
The current Dorman Products [DORM] share price is $111.18. The Score for DORM is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
-
DORM is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
-
The current Alnylam Pharmaceuticals [ALNY] share price is $234.56. The Score for ALNY is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
-
ALNY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
DORM Stock Price Chart
What is Dorman Products's stock price today?
-
The Dorman Products share price today is $111.18The current trend is moderately bullish and DORM is experiencing slight selling pressure.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $234.56Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing buying pressure, which is a positive indicator for future bullish movement.
DORM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 17.64 | Buy |
Relative Strength Index (14 RSI): | 35.74 | Sell |
Chaikin Money Flow: | -111664 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (113.92 - 126.1) | Sell |
Bollinger Bands (100): | (121.2 - 135.96) | Sell |
ALNY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -6.82 | Sell |
Relative Strength Index (14 RSI): | 44.36 | Sell |
Chaikin Money Flow: | 492014 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (233.31 - 270.77) | Sell |
Bollinger Bands (100): | (237.35 - 266.99) | Sell |
DORM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 113.09 | Sell |
20-day SMA: | 118.36 | Sell |
50-day SMA: | 123.8 | Sell |
200-day SMA: | 119.47 | Sell |
8-day EMA: | 112.59 | Sell |
20-day EMA: | 101.6 | Buy |
50-day EMA: | 66.76 | Buy |
200-day EMA: | 22.43 | Buy |
ALNY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 233.46 | Buy |
20-day SMA: | 252.74 | Sell |
50-day SMA: | 253.19 | Sell |
200-day SMA: | 258.73 | Sell |
8-day EMA: | 236.18 | Sell |
20-day EMA: | 244.09 | Sell |
50-day EMA: | 250.46 | Sell |
200-day EMA: | 244.21 | Sell |
Dorman Products Earnings Growth & DORM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.56 per share, a decrease next quarter of $0.49 per share, an increase this year of $0.79 per share, and an increase next year of $0.66 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.95 per share, an increase next quarter of $1.35 per share, an increase this year of $1.05 per share, and an increase next year of $2.86 per share.
Dorman Products Technical Analysis
Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Alnylam Pharmaceuticals Technical Analysis
Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |